{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:31:44Z","timestamp":1790217104452,"version":"4.1.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Osteoporosis is a widespread condition among the elderly, with a particularly high incidence in postmenopausal women aged 50 and above. This disease significantly increases the risk of fractures, adversely affecting the quality of life. <jats:italic>Epimedium<\/jats:italic>, a traditional Chinese medicinal herb, has been widely used in the treatment of osteoporosis due to its diverse therapeutic properties. However, <jats:italic>Epimedium<\/jats:italic> contains a complex mixture of compounds, including both beneficial and potentially harmful constituents. Therefore, there is a critical need to identify and isolate active monomeric compounds that can effectively treat osteoporosis, thereby enhancing the specificity and efficacy of treatment while reducing the intake of harmful substances. Through an integrated approach utilizing network pharmacology and extensive literature review, we identified five previously unreported anti-osteoporotic monomeric compounds from various traditional agents: Epimedin A (EA), Epimedin B (EB), Epimedoside A (EPA), 4-Hydroxybenzaldehyde (PHBA), and Baohuoside VI. We subsequently evaluated the effects of these compounds on bone marrow-derived macrophages (BMMs) and cranial preosteoblasts. Results from tartrate-resistant acid phosphatase (TRAP) staining and quantitative polymerase chain reaction (qPCR) demonstrated that EA, EB, and EPA significantly inhibited BMM differentiation into osteoclasts in a dose-dependent manner. In contrast, alkaline phosphatase (ALP) staining, Alizarin Red staining, and qPCR results showed that EA and EB promoted the differentiation of cranial preosteoblasts into osteoblasts in a dose-dependent fashion. Furthermore, intraperitoneal administration of EA and EB at doses of 5\u00a0mg\/kg, 10\u00a0mg\/kg, and 20\u00a0mg\/kg in ovariectomized (OVX) mice resulted in a significant increase in bone mineral density and trabecular bone number compared to the OVX group (P &amp;lt; 0.05 compared to OVX group). These findings suggest that EA and EB may mitigate bone loss in OVX mice. Importantly, high doses of EA and EB did not exhibit pharmacological toxicity in various organs, as confirmed by hematoxylin and eosin (HE) staining. In exploring the underlying mechanisms, we found that EA and EB do not modulate the NF-\u03baB signaling pathway, as indicated by the NFKB luciferase reporter assay. Western blot analysis further revealed that EA and EB might not affect osteoporosis progression via the MAPK (ERK and JNK) or NF-\u03baB (P65 and I\u03baB\u03b1) pathways. To elucidate the molecular targets, we utilized PharmMapper, Similarity Ensemble Approach, SwissTargetPrediction, and SuperPred to predict potential targets of EA and EB. Intersection analysis using the Ingenuity Pathway Analysis (IPA) database indicated that EA and EB regulate the focal adhesion kinase (FAK) signaling pathway. Molecular docking studies using Autodock confirmed the binding of EA and EB to FAK1 (binding free energy: \u221213.012\u00a0kJ\/mol and \u221214.0164\u00a0kJ\/mol) and FAK2 (binding free energy: \u22125.815\u00a0kJ\/mol and \u22126.4852\u00a0kJ\/mol). qPCR analysis further demonstrated that EA and EB significantly inhibited FAK1 and FAK2 gene expression in osteoclasts while promoting their expression in osteoblasts at very high doses. In conclusion, EA and EB, identified as active monomeric compounds in <jats:italic>Epimedium<\/jats:italic>, may exert their anti-osteoporotic effects by modulating the FAK signaling pathway, thereby enhancing bone mineral density and improving the quality of life for patients with osteoporosis. This study provides new insights into the pathogenesis of osteoporosis and the development of targeted anti-osteoporosis therapies. Further research is warranted to validate the role of EA and EB in modulating osteoporosis progression via the FAK signaling pathway.<\/jats:p>","DOI":"10.3389\/fphar.2025.1532665","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:23:17Z","timestamp":1751444597000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Integrating network pharmacology, IPA, and molecular docking to reveal the anti-osteoporosis effects of EA and EB via the FAK pathway"],"prefix":"10.3389","volume":"16","author":[{"given":"Ziheng","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/BOR.0000000000000401","article-title":"Fracture liaison services","volume":"29","author":"Briot","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"24245","DOI":"10.1038\/srep24245","article-title":"Drug target identification using network analysis: taking active components in Sini decoction as an example","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1039\/c4mb00048j","article-title":"Investigation of the therapeutic effectiveness of active components in Sini decoction by a comprehensive GC\/LC-MS based metabolomics and network pharmacology approaches","volume":"10","author":"Chen","year":"2014","journal-title":"Mol. Biosyst."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"B5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.cger.2014.01.001","article-title":"Epidemiology of fragility fractures","volume":"30","author":"Friedman","year":"2014","journal-title":"Clin. Geriatr. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","journal-title":"J. Bone Min. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.mcna.2022.10.013","article-title":"Osteoporosis","volume":"107","author":"Gopinath","year":"2023","journal-title":"Med. Clin. North Am."},{"key":"B8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jare.2021.06.020","article-title":"Plastid genome data provide new insights into the phylogeny and evolution of the genus Epimedium","volume":"36","author":"Guo","year":"2022","journal-title":"J. Adv. Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pharmthera.2016.01.015","article-title":"Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health","volume":"162","author":"Indran","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J. Bone Min. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1111\/bph.15024","article-title":"Overview of treatment approaches to osteoporosis","volume":"178","author":"Langdahl","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1142\/S0192415X19500253","article-title":"The role of Chinese medicine in health maintenance and disease prevention: application of constitution theory","volume":"47","author":"Li","year":"","journal-title":"Am. J. Chin. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/economies7020056","article-title":"Foreign trade structure, opening degree and economic growth in western China","volume":"7","author":"Li","year":"","journal-title":"Economies"},{"key":"B14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","article-title":"Traditional Chinese medicine network pharmacology: theory, methodology and application","volume":"11","author":"Li","year":"2013","journal-title":"Chin. J. Nat. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1875-5364(23)60429-7","article-title":"Network pharmacology approaches for research of Traditional Chinese Medicines","volume":"21","author":"Li","year":"2023","journal-title":"Chin. J. Nat. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e72233","DOI":"10.1371\/journal.pone.0072233","article-title":"The effect of differentiation induction on FAK and Src activity in live HMSCs visualized by FRET","volume":"8","author":"Liao","year":"2013","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e42709","DOI":"10.1371\/journal.pone.0042709","article-title":"Visualization of Src and FAK activity during the differentiation process from HMSCs to osteoblasts","volume":"7","author":"Liao","year":"2012","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13020-022-00632-5","article-title":"Serum metabolomics analysis of deficiency pattern and excess pattern in patients with rheumatoid arthritis","volume":"17","author":"Liu","year":"2022","journal-title":"Chin. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10856-020-06472-9","article-title":"Development of epimedin A complex drugs for treating the osteoporosis","volume":"32","author":"Liu","year":"2021","journal-title":"J. Mater Sci. Mater Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jep.2011.01.001","article-title":"The genus Epimedium: an ethnopharmacological and phytochemical review","volume":"134","author":"Ma","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41419-023-05680-9","article-title":"Honokiol suppresses the aberrant interactions between renal resident macrophages and tubular epithelial cells in lupus nephritis through the NLRP3\/IL-33\/ST2 axis","volume":"14","author":"Ma","year":"2023","journal-title":"Cell Death Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1097\/GME.0000000000001831","article-title":"Management of osteoporosis in postmenopausal women: the 2021 position statement of the North American Menopause Society","volume":"28","author":"Author anonymous","year":"2021","journal-title":"Menopause"},{"key":"B23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1517\/17460441.2016.1117070","article-title":"An overview of molecular fingerprint similarity search in virtual screening","volume":"11","author":"Muegge","year":"2016","journal-title":"Expert Opin. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1189\/jlb.0512259","article-title":"Regulation of osteoclast structure and function by FAK family kinases","volume":"92","author":"Ray","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/bph.13631","article-title":"Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery","volume":"174","author":"Shen","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fphar.2018.00981","article-title":"Bone health and natural products- an insight","volume":"9","author":"Suvarna","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"770344","DOI":"10.3389\/fphar.2022.770344","article-title":"Lipophilic constituents in salvia miltiorrhiza inhibit activation of the hepatic stellate cells by suppressing the JAK1\/STAT3 signaling pathway: a network pharmacology study and experimental validation","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13020-023-00788-8","article-title":"Effects of genus Epimedium in the treatment of osteoarthritis and relevant signaling pathways","volume":"18","author":"Tong","year":"2023","journal-title":"Chin. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11914-010-0023-2","article-title":"Timing of subsequent fractures after an initial fracture","volume":"8","author":"van Geel","year":"2010","journal-title":"Curr. Osteoporos. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1136\/ard.2008.092775","article-title":"Clinical subsequent fractures cluster in time after first fractures","volume":"68","author":"van Geel","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"111977","DOI":"10.1016\/j.jep.2019.111977","article-title":"Integrated pathological cell fishing and network pharmacology approach to investigate main active components of Er-Xian decotion for treating osteoporosis","volume":"241","author":"Wang","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.2174\/1389450118666170321105425","article-title":"Therapeutic potential and outlook of alternative medicine for osteoporosis","volume":"18","author":"Wang","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"B34","doi-asserted-by":"publisher","first-page":"106435","DOI":"10.1016\/j.compbiomed.2022.106435","article-title":"Network pharmacology and LC-MS approachs to explore the active compounds and mechanisms of Yuanjiang decoction for treating bradyarrhythmia","volume":"152","author":"Wang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fphar.2018.00525","article-title":"The active components of fuzheng huayu formula and their potential mechanism of action in inhibiting the hepatic stellate cells viability - a network pharmacology and transcriptomics approach","volume":"9","author":"Xing","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1359\/jbmr.081102","article-title":"Focal adhesion kinase is important for fluid shear stress-induced mechanotransduction in osteoblasts","volume":"24","author":"Young","year":"2009","journal-title":"J. Bone Min. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11657-018-0549-y","article-title":"The epidemiology of osteoporosis, associated fragility fractures, and management gap in China","volume":"14","author":"Yu","year":"2019","journal-title":"Arch. Osteoporos."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1359\/jbmr.070405","article-title":"Epimedium-derived phytoestrogen flavonoids exert beneficial effect on preventing bone loss in late postmenopausal women: a 24-month randomized, double-blind and placebo-controlled trial","volume":"22","author":"Zhang","year":"2007","journal-title":"J. Bone Min. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"bbad518","DOI":"10.1093\/bib\/bbad518","article-title":"Network pharmacology: towards the artificial intelligence-based precision traditional Chinese medicine","volume":"25","author":"Zhang","year":"2023","journal-title":"Brief. Bioinform"},{"key":"B40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12013-013-9799-x","article-title":"Icariin enhances radiosensitivity of colorectal cancer cells by suppressing NF-\u03baB activity","volume":"69","author":"Zhang","year":"2014","journal-title":"Cell Biochem. Biophys."},{"key":"B41","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1080\/21691401.2019.1631838","article-title":"FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells","volume":"47","author":"Zheng","year":"2019","journal-title":"Artif. Cells Nanomed Biotechnol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1532665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T08:23:18Z","timestamp":1751444598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1532665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":42,"alternative-id":["10.3389\/fphar.2025.1532665"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1532665","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1532665"}}